AIBOTICS, INC.
AIBT · OTCMCIK 1763329fmd_1WEX2FNTMJ6RFTGCBM4HKPHQZFManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2018 to Jun 30, 2026, 34 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | – | – | – | – | 0 | 0 |
| Cost of revenue | 0 | 0 | – | – | – | – | – | – |
| Gross profit | 0 | 0 | – | – | – | – | 0 | 0 |
| Compensation and benefits | 0 | 0 | – | – | – | – | – | – |
| Total operating expenses | 0 | 0 | 0 | 5 | 2 | 1 | 2 | 2 |
| Operating income | (0) | (0) | (0) | (5) | (2) | (1) | (2) | (2) |
| Interest expense | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Interest and investment income | 0 | 0 | – | – | – | – | – | – |
| Other non-operating income (expense) | 0 | (0) | (0) | (0) | (1) | (1) | (0) | (0) |
| Income before taxes | (0) | (0) | (0) | (5) | (3) | (1) | (2) | (2) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (0) | (0) | (0) | (5) | (3) | (1) | (2) | (2) |
| Net income | 0 | 0 | (0) | (5) | (3) | (1) | (2) | (2) |
| Net income to common shareholders | – | – | – | – | – | – | (0) | (0) |